Costa-Font, Joan; Rudisill, Caroline; Tan, Stefanie - In: Health Policy 116 (2014) 2, pp. 224-233
The sluggish development of European generic drug markets depends heavily on demand side factors, and more specifically, patients’ and doctors’ loyalty to branded products. Loyalty to originator drugs, to the point where originator prices rise upon generic entry has been described as the...